&nbsp;

QuitSmokingBrochure.pdf

Jul 2020

Document

QuitSmokingBrochure-FR.pdf

Jul 2020

Regimen

DCRBDOXO

Cancer Type:

Sarcoma,

Soft Tissue

Intent: Adjuvant, Curative, Palliative

Drugs Used:

dacarbazine,

DOXOrubicin

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2020

Regimen

DEXAPOMA+ISAT

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

New Drug Funding Program

Isatuximab - In Combination with Pomalidomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Exceptional Access Program

pomalidomide - In combination with isatuximab and dexamethasone for relapsed or refractory multiple myeloma, according to specific criteria

Drugs Used:

Quick Link(s):

Regimen Monograph

Feb 2024

Regimen

DEXASELI

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

selinexor (Unfunded),

dexamethasone

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2020

Quality Expectations by Disease Site – Radiation Treatment

Cancer facts

Diabetes leads to increased risk of dying among First Nations women with breast cancer in Ontario

Nov 2020

Regimen

DURV(MNT)

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Durvalumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Drugs Used:

durvalumab

... Show more tags

Quick Link(s):

Regimen Monograph

Apr 2024

Drug

darolutamide

Other Name(s): Nubeqa®

Quick Link(s): Drug Monograph, Patient Info Sheet

Mar 2024

Dépistage du cancer pendant la COVID-19: Messages à l’intention des fournisseurs de soins de santé

Document

QualityAwardCriteriaChecklist2021-FR.pdf

May 2021

Document